Initial clinical experience performing sialendoscopy for salivary gland protection in patients undergoing 225Ac-PSMA-617 RLT

被引：0
|
作者：
Hendrik Rathke
Clemens Kratochwil
Ralph Hohenberger
Frederik Lars Giesel
Frank Bruchertseifer
Paul Flechsig
Alfred Morgenstern
Matti Hein
Peter Plinkert
Uwe Haberkorn
Olcay Cem Bulut
机构：
[1] Heidelberg University Hospital,Department of Nuclear Medicine
[2] Heidelberg University Hospital,Department of Otorhinolaryngology, Head and Neck Surgery (ORL
[3] Joint Research Centre,HNS)
[4] SLK Klinikum Am Gesundbrunnen,Directorate for Nuclear Safety and Security, European Commission
[5] German Cancer Research Center (DKFZ),Department of Otorhinolaryngology, Head and Neck Surgery
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2019年 / 46卷
关键词：
PSMA-617; Ac-225; TAT; Xerostomia; PSMA-RLT;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：139 / 147
页数：8
相关论文
共 41 条
  • [21] Re: 225Ac-PSMA-617 for PSMA-Targeting Alpha-radiation Therapy of Patients with Metastatic Castration-resistant Prostate Cancer
    Hadaschik, Boris
    EUROPEAN UROLOGY, 2016, 70 (06) : 1080 - 1081
  • [22] 225Ac-PSMA-617 targeted alpha therapy after Docetaxel based chemotherapy in the patients of metastatic castration resistant prostate cancer
    Sen, Ishita
    Pant, Vineet
    Thakral, Parul
    Raina, Vinod
    Das, Subha
    Sharma, Kanchan
    Manda, Divya
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [23] 225Ac-PSMA-617 radioligand therapy of de novo metastatic hormone-sensitive prostate carcinoma (mHSPC): preliminary clinical findings
    Mike Sathekge
    Frank Bruchertseifer
    Mariza Vorster
    Ismaheel O. Lawal
    Kgomotso Mokoala
    Janet Reed
    Letjie Maseremule
    Honest Ndlovu
    Khanyi Hlongwa
    Alex Maes
    Alfred Morgenstern
    Christophe Van de Wiele
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 2210 - 2218
  • [24] 225Ac-PSMA-617 radioligand therapy of de novo metastatic hormone-sensitive prostate carcinoma (mHSPC): preliminary clinical findings
    Sathekge, Mike
    Bruchertseifer, Frank
    Vorster, Mariza
    Lawal, Ismaheel O.
    Mokoala, Kgomotso
    Reed, Janet
    Maseremule, Letjie
    Ndlovu, Honest
    Hlongwa, Khanyi
    Maes, Alex
    Morgenstern, Alfred
    Van de Wiele, Christophe
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (07) : 2210 - 2218
  • [25] Dose escalation experience with Ac-225-PSMA-617 in PSMA targeting alpha-radiation therapy of patients with mCRPC
    Kratochwil, C.
    Bruchertseifer, F.
    Giesel, F. L.
    Apostolidis, C.
    Haberkorn, U.
    Morgenstern, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S51 - S51
  • [26] Ac-225-PSMA617-a single center experience of 40 patients receiving PSMA-targeted Alpha therapy
    Kratochwil, Clemens
    Giesel, Frederik
    Bruchertseifer, Frank
    Rius-Montraveta, Maria
    Apostolidis, Christos
    Haberkorn, Uwe
    Morgenstern, Alfred
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [27] mCRPC Patients Receiving 225Ac-PSMA-617 Therapy in the Post-Androgen Deprivation Therapy Setting: Response to Treatment and Survival Analysis
    Sathekge, Mike
    Bruchertseifer, Frank
    Vorster, Mariza
    Lawal, Ismaheel O.
    Knoesen, Otto
    Mahapane, Johncy
    Davis, Cindy
    Mdlophane, Amanda
    Maes, Alex
    Mokoala, Kgomotso
    Mathabe, Kgomotso
    Van de Wiele, Christophe
    Morgenstern, Alfred
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (10) : 1496 - 1502
  • [28] 225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study (vol 46, pg 129, 2019)
    Sathekge, Mike
    Bruchertseifer, Frank
    Knoesen, Otto
    Reyneke, Florette
    Lawal, Ismaheel
    Lengana, Thabo
    Davis, Cindy
    Mahapane, Johncy
    Corbett, Ceceila
    Vorster, Mariza
    Morgenstern, Alfred
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (10) : 1988 - 1988
  • [29] Clinical experience with PSMA-Actinium-225 (Ac-225) radioligand therapy (RLT) in end-stage metastatic castration-resistant prostate cancer (mCRPC) patients.
    van der Doelen, Maarten Johannes
    Mehra, Niven
    Smits, Minke
    van Oort, Inge M.
    Janssen, Marcel J. R.
    Haberkorn, Uwe
    Kratochwil, Clemens
    Gerritsen, Winald
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [30] Therapeutic efficacy of 225Ac-PSMA-617 targeted alpha therapy in patients of metastatic castrate resistant prostate cancer after taxane-based chemotherapy
    Ishita Sen
    Parul Thakral
    Priya Tiwari
    Vineet Pant
    Subha Shankar Das
    Divya Manda
    Vinod Raina
    Annals of Nuclear Medicine, 2021, 35 : 794 - 810
12345